FDA Going Full Speed on CBD Regs
According to FDA Acting Chief Information Officer Amy Abernethy, “The FDA is expediting its work to address the many questions about cannabidiol (CBD),” describing it as “an important national issue with public health impact and an important topic for American hemp farmers and many other stakeholders.” “We are enthusiastic about research into the therapeutic benefits…